Vermillion Inc operates in the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Vermillion Inc with three other
companies in this sector in the United States:
Interleukin Genetics, Inc.
sales of $1.44 million
American Cannabis Company Inc
Akers Biosciences Incorporation
of which 100%
was Diagnostic Screening).
Vermillion Inc reported sales of $2.18 million
December of 2015.
decrease of 13.6%
versus 2014, when the company's sales were $2.52 million.